Akèy › Kansè Poumon ki pa ti selil › North Carolina › Raleigh
Etid klinik pou Kansè Poumon ki pa ti selil nan Raleigh, NC
4 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Raleigh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Ap rekriteFaz 3
- WakeMed Raleigh Campus ( Site 3214), Raleigh
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Ap rekriteFaz 3
- WakeMed Raleigh Campus ( Site 0144), Raleigh
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Duke Cancer Center Raleigh, Raleigh
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- WakeMed Raleigh Campus, Raleigh
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Raleigh
- Ensifizyans kadyak7 etid
- Maladi atè koronè6 etid
- Obèsite6 etid
- Dyabèt Tip 26 etid
- Degeneresans makile6 etid
- Ateroskleroz5 etid
- Sipwa5 etid
- Maladi kadyovaskilè5 etid
- Kansè Endomèt5 etid
- Akidan serebavaskilè5 etid
- Ensifizans renn4 etid
- Dyabèt4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.